1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Therapy Analysis & Statistics (p200)

Global Therapy Analysis & Statistics (p200)

5971-6000 of about 7200 reports

LAG-3 Antagonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "LAG-3 Antagonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the LAG-3 Antagonist ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Leukotriene Antagonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Leukotriene Antagonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Leukotriene ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Leukotriene D4 Antagonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Leukotriene D4 Antagonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Lipoxygenase Inhibitor (LOX Inhibitor) -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Lipoxygenase Inhibitor (LOX Inhibitor) - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Lysine Specific Demethylase 1 (LSD-1) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Lysine Specific Demethylase 1 (LSD-1) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Matrix Metalloproteinase (MMP) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 120 pages

Overview "Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across ...

  • World
  • Immunotherapy
  • Therapy
  • Industry analysis
  • Health Expenditure

Matrix Metalloproteinase 9 (MMP-9) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Melanocortin 4 Receptor (MC4R) Agonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Metabotropic Glutamate Receptor Agonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Methionine Aminopeptidase 2 (Metap2) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Methionine Aminopeptidase 2 (Metap2) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

mGlu 2/3 Agonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "mGlu 2/3 Agonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the mGlu 2/3 ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

mGlu 2/3/5 Antagonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "mGlu 2/3/5 Antagonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the mGlu ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

mGlu5 Antagonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "mGlu5 Antagonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the mGlu5 Antagonist ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Mitochondrial Electron Transport Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Mitochondrial Electron Transport Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism ...

  • World
  • Therapy
  • Hormone
  • Industry analysis
  • Health Expenditure

Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism ...

  • World
  • Therapy
  • Hormone
  • Industry analysis
  • Health Expenditure

Monoamine Oxidase Inhibitor (MAOIs) -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Monoamine Oxidase Inhibitor (MAOIs) - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Monoamine Oxidase B (MAO-B) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Monoamine Oxidase B (MAO-B) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

mTORC-1 Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "mTORC-1 Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the mTORC-1 ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

mTORC-2 Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "mTORC-2 Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the mTORC-2 ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Mu Antagonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Mu Antagonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Mu Antagonist ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Murine Double Minute 2 (MDM2) Inhibitor -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Muscarinic Acetylcholine Receptor (mAChR) Antagonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 90 pages

Overview "Muscarinic Acetylcholine Receptor (mAChR) Antagonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Muscarinic Acetylcholine Receptor M2 Antagonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Muscarinic Acetylcholine Receptor M3 Antagonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Muscarinic Agonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Muscarinic Agonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Muscarinic ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure

Muscarinic M1 Agonist -Pipeline Insight, 2020

  • $ 1500
  • June 2020
  • 60 pages

Overview "Muscarinic M1 Agonist - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Muscarinic ...

  • World
  • Therapy
  • Industry analysis
  • Health Expenditure
About 15000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Global Infectious Disease and Vaccine Demographic Impact

  • September 2021
  • 25 pages
  • World
  • Infectious Disease
  • Vaccine
  • Industry analysis
  • Cause-Specific Mortality Rate

Global Economic Analysis September 2021

US Economic Analysis September 2021

Global Economic Analysis September 2021

US Economic Analysis September 2021

Global Economic Analysis September 2021


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on